Frontier Biology (688221.SH): The freeze-dried powder injection production line passed the drug GMP compliance inspection

Zhitongcaijing · 06/03 11:25

Zhitong Finance App News, Frontier Biology (688221.SH) issued an announcement. The company recently received the “Drug GMP Conformity Inspection Results Notice” (2024 No. 176) issued by the Jiangsu Drug Administration. The company's freeze-dried powder injection production line located in Jiangning District of Nanjing City underwent on-site inspection by the Jiangsu Drug Administration and met the requirements of the “Pharmaceutical Production Quality Management Code”.